Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call Transcript
12:16pm, Wednesday, 29'th Oct 2025
United Therapeutics Corporation ( UTHR ) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants Harrison Silvers - Manager of Investor Relations Martine Rothblatt - Founder, Chairman
Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key Metrics
10:36am, Wednesday, 29'th Oct 2025
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare w
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
08:51am, Wednesday, 29'th Oct 2025
Shares of United Therapeutics slipped slightly Wednesday on light sales of its bread-and-butter drug, Tyvaso.
United Therapeutics (UTHR) Beats Q3 Earnings Estimates
08:41am, Wednesday, 29'th Oct 2025
United Therapeutics (UTHR) came out with quarterly earnings of $7.16 per share, beating the Zacks Consensus Estimate of $6.89 per share. This compares to earnings of $6.39 per share a year ago.
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
06:30am, Wednesday, 29'th Oct 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced record financial results for the quart
United Therapeutics Corporation (NASDAQ:UTHR) Receives Consensus Rating of “Moderate Buy” from Analysts
01:53am, Sunday, 26'th Oct 2025
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen research firms that are covering the company, MarketBeat rep
Sequoia Financial Advisors LLC Purchases 400 Shares of United Therapeutics Corporation $UTHR
06:33am, Thursday, 23'rd Oct 2025
Sequoia Financial Advisors LLC boosted its position in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 60.0% in the undefined quarter, according to its most recent filing with the Securiti
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Wednesday, 22'nd Oct 2025
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Wednesday, 22'nd Oct 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Cwm LLC Boosts Stake in United Therapeutics Corporation $UTHR
04:57am, Tuesday, 21'st Oct 2025
Cwm LLC boosted its position in United Therapeutics Corporation (NASDAQ: UTHR) by 204.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchan
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
07:00am, Wednesday, 15'th Oct 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2025 financial results before t
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting
07:00am, Monday, 13'th Oct 2025
SILVER SPRING, Md., & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming CHE
Is IPF the Next Big Market Opportunity for United Therapeutics?
11:41am, Wednesday, 01'st Oct 2025
UTHR reports strong TETON-2 results for Tyvaso in IPF, showing lung function gains and eyeing a major new market.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 01'st Oct 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
United Therapeutics Corporation - Special Call
05:27pm, Sunday, 28'th Sep 2025
United Therapeutics Corporation - Special Call Company Participants Harrison Silvers - Manager of Investor Relations Leigh Peterson - Executive Vice President of Product Development & Xenotransplantat
